SMITH & NEPHEW PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,024 GBX | -0.15% |
|
+1.89% | -5.10% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 5.82B | Sales 2025 * | 6.12B | Capitalization | 11.34B |
|---|---|---|---|---|---|
| Net income 2024 * | 541M | Net income 2025 * | 694M | EV / Sales 2024 * | 2.39 x |
| Net Debt 2024 * | 2.56B | Net Debt 2025 * | 2.23B | EV / Sales 2025 * | 2.22 x |
| P/E ratio 2024 * |
22.1
x | P/E ratio 2025 * |
16.9
x | Employees | 18,452 |
| Yield 2024 * |
2.94% | Yield 2025 * |
3.3% | Free-Float | 99.15% |
More Fundamentals
* Assessed data
More news
Latest transcript on Smith & Nephew Plc
More recommendations
More press releases
More news
| 1 day | -0.15% | ||
| 1 week | +1.89% | ||
| Current month | +4.55% | ||
| 1 month | +6.59% | ||
| 3 months | -8.37% | ||
| 6 months | -0.10% | ||
| Current year | -5.10% |
1 week
998.40
1 030.00
1 month
954.001 030.00
Current year
946.001 181.50
1 year
887.001 302.00
3 years
887.001 601.50
5 years
887.002 023.00
10 years
881.002 023.00
| Managers | Title | Age | Since |
|---|---|---|---|
Deepak Nath
CEO | Chief Executive Officer | - | 22-03-31 |
John Rogers
DFI | Director of Finance/CFO | 56 | Nov. 30 |
Alison Parkes
CMP | Compliance Officer | - | 99-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Marc E. Owen
BRD | Director/Board Member | 65 | 17-09-30 |
Jeremy Maiden
BRD | Director/Board Member | 62 | 23-09-13 |
Rupert Soames
CHM | Chairman | 63 | 23-04-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.16% | 14 M€ | -3.66% | ||
| 0.52% | 11 M€ | +0.83% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 1,024 | -0.15% | 2,425,623 |
| 24-05-16 | 1,025 | +0.49% | 1,647,107 |
| 24-05-15 | 1,020 | +0.20% | 2,323,465 |
| 24-05-14 | 1,018 | +1.14% | 1,875,429 |
| 24-05-13 | 1,006 | +0.20% | 1,376,439 |
Delayed Quote London S.E., May 17, 2024 at 11:35 am EDT
More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13
USD
Average target price
16.35
USD
Spread / Average Target
+25.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.10% | 11.34B | |
| +4.02% | 9.11B | |
| +38.12% | 5.53B | |
| -23.70% | 4.61B | |
| +8.55% | 3.45B | |
| -6.44% | 2.87B | |
| -5.85% | 2.1B | |
| -11.84% | 2.08B | |
| -23.36% | 1.78B | |
| -9.29% | 1.14B |
- Stock Market
- Equities
- SN. Stock
